Plain-English translation of NCT05683873 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
After a stroke, the heart can sometimes be damaged even though the stroke affected the brain. Researchers want to understand this connection better by measuring a protein in the blood called GDF-15 and checking the heart's function with recordings and ultrasounds. This study will help doctors figure out whether GDF-15 can warn them about heart damage after stroke.
Doctors know that stroke and heart damage are connected, but they don't fully understand why some stroke patients develop heart problems. Finding a blood test that can predict this heart damage early might help doctors treat patients better and prevent serious complications.
You likely qualify if…
You likely don't qualify if…
You will have 4 visits over about 4 to 6 months. At your first visit (within 24 hours of stroke symptoms), you'll give consent and have baseline tests. Over the next 1–2 days, you'll have blood tests, a heart rhythm recording (EKG), and heart ultrasounds during your hospital stay. Then you'll return for a final follow-up visit 4–6 months later for more heart tests. The main procedures are simple blood draws and non-invasive heart monitoring.
AI-generated summary from trial data · Jun 22, 2026 · Not medical advice
France
Sponsor
Centre Hospitalier Universitaire Dijon
Enrollment target
~130 participants
Started
February 2023
Primary completion
August 2027
Age range
18 Years and older
Last updated on clinicaltrials.gov in January 2025.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Yannick BEJOT
Centre Hospitalier Universitaire Dijon
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.